Investments	Shares		Value

COMMON STOCKS–99.9%

Automobiles - 10.2%
Tesla, Inc.*		4,149,851	$	681,862,018

Biotechnology - 18.9%
Beam Therapeutics, Inc.*^†		6,137,270		188,475,562
CRISPR Therapeutics AG (Switzerland)*^†		5,394,286		263,996,357
Exact Sciences Corp.*		5,983,169		383,341,638
Intellia Therapeutics, Inc.*^†		6,770,857		255,599,852
Twist Bioscience Corp.*^†		3,710,516		46,307,239
Veracyte, Inc.*^†		4,609,315		104,354,891
Verve Therapeutics, Inc.*		1,703,745		27,140,658
Total Biotechnology				1,269,216,197

Capital Markets - 8.7%
Coinbase Global, Inc., Class A*		7,684,573		413,353,182
Robinhood Markets, Inc., Class A*		19,135,407		169,348,352
Total Capital Markets				582,701,534

Chemicals - 2.0%
Ginkgo Bioworks Holdings, Inc.*^†		109,828,155		133,990,349

Diversified Consumer Services - 0.5%
2U, Inc.*^†		6,102,611		33,808,465

Entertainment - 11.4%
ROBLOX Corp., Class A*		6,953,332		247,538,619
Roku, Inc.*^†		9,228,132		518,713,300
Total Entertainment				766,251,919

Financial Services - 6.0%
Block, Inc.*		6,672,965		405,649,542

Health Care Equipment & Supplies - 0.5%
Cerus Corp.*^†		13,589,158		31,390,955

Health Care Providers & Services - 0.4%
Invitae Corp.*^†		18,210,990		24,766,946

Health Care Technology - 4.7%
Teladoc Health, Inc.*^†		11,849,533		314,368,110

Hotels, Restaurants & Leisure - 4.8%
DraftKings, Inc., Class A*		14,772,647		323,668,696

IT Services - 8.0%
Shopify, Inc., Class A (Canada)*		6,765,307		327,779,124
Twilio, Inc., Class A*		3,999,412		210,409,065
Total IT Services				538,188,189

Life Sciences Tools & Services - 4.2%
10X Genomics, Inc., Class A*		2,492,214		130,666,780
Pacific Biosciences of California, Inc.*^†		13,943,716		147,803,390
Total Life Sciences Tools & Services				278,470,170

Software - 19.6%
PagerDuty, Inc.*^†		7,200,780		216,455,447
UiPath, Inc., Class A*^†		25,766,535		362,792,813
Unity Software, Inc.*		8,692,496		234,436,617
Zoom Video Communications, Inc., Class A*		8,244,754		506,475,238
Total Software				1,320,160,115
Total Common Stocks
(Cost $18,529,484,535)				6,704,493,205

Investments	Shares		Value
MONEY MARKET FUND–0.0%^(a)
Goldman Sachs Financial Square Treasury Obligations Fund, 4.70%^(b)
(Cost $1,261,828)	1,261,828	$	1,261,828
Total Investments–99.9%
(Cost $18,530,746,363)			6,705,755,033
Other Assets in Excess of Liabilities–0.1%			8,207,896
Net Assets–100.0%		$	6,713,962,929

*	Non-income producing security
†	Affiliated security
(a)	Less than 0.05%
(b)	Rate shown represents annualized 7-day yield as of April 30, 2023.

An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period to date transactions with companies which are or were affiliates are as follows:

The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:

• Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).

• Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the valuations as of April 30, 2023, based upon the three levels defined above:

	Value ($) at 7/31/2022		Purchases Cost ($)		Sales Proceeds ($)			Net Realized Gain/(Loss) ($)			Net Change in Unrealized Appreciation (Depreciation) ($)			Dividend Income ($)		Capital Gain Distributions ($)		Number of Shares at 4/30/2023		Value ($) at 4/30/2023
Common Stocks — 39.4%
Biotechnology — 12.8%
Beam Therapeutics, Inc.
		425,310,301		300,334,851		(337,779,929	)		(9,076,268	)		(190,313,393	)		–		–		6,137,270		188,475,562
CRISPR Therapeutics AG
		475,632,825		330,526,846		(398,714,804	)		(29,585,990	)		(113,862,520	)		–		–		5,394,286		263,996,357
Exact Sciences Corp. ^{^}
		453,419,254		573,445,458		(861,912,477	)		(276,763,310	)		495,152,713			–		–		5,983,169		383,341,638
Fate Therapeutics, Inc.
		218,139,689		101,734,810		(176,613,866	)		(460,303,352	)		317,042,719			–		–		–		–
Intellia Therapeutics, Inc.
		430,810,590		368,969,439		(364,173,813	)		(14,742,274	)		(165,264,090	)		–		–		6,770,857		255,599,852
Twist Bioscience Corp.
		178,879,891		117,386,179		(128,592,472	)		(2,033,730	)		(119,332,629	)		–		–		3,710,516		46,307,239
Veracyte, Inc.
		137,390,204		118,667,909		(134,947,729	)		(3,945,523	)		(12,809,970	)		–		–		4,609,315		104,354,891
Chemicals — 2.0%
Ginkgo Bioworks Holdings, Inc.
		200,265,720		291,093,580		(208,756,347	)		5,796,973			(154,409,577	)		–		–		109,828,155		133,990,349
Diversified Consumer Services — 0.5%
2U, Inc.
		64,267,072		53,216,975		(56,403,607	)		(2,277,972	)		(24,994,003	)		–		–		6,102,611		33,808,465
Entertainment — 7.7%
Roku, Inc.
		597,014,440		656,576,382		(660,126,495	)		(61,492,485	)		(13,258,542	)		–		–		9,228,132		518,713,300
Health Care Equipment & Supplies — 0.5%
Cerus Corp.
		64,337,431		51,132,169		(48,398,662	)		(1,657,288	)		(34,022,695	)		–		–		13,589,158		31,390,955
Health Care Providers & Services — 0.4%
Invitae Corp.
		35,214,655		53,045,530		(51,736,359	)		(9,023,006	)		(2,733,874	)		–		–		18,210,990		24,766,946
Signify Health, Inc.
		228,647,398		35,421,530		(394,887,375	)		75,598,078			55,220,369			–		–		–		–
Health Care Technology — 4.7%
Teladoc Health, Inc.
		439,542,710		388,586,710		(389,544,540	)		(17,455,207	)		(106,761,563	)		–		–		11,849,533		314,368,110
Life Sciences Tools & Services — 2.2%
Berkeley Lights, Inc.
		18,250,247		3,223,900		(16,632,802	)		(139,777,712	)		134,936,367			–		–		–		–
Compugen Ltd.
		9,521,030		472,118		(8,473,835	)		(51,068,846	)		49,549,533			–		–		–		–
Pacific Biosciences of California, Inc.
		61,525,177		143,970,939		(145,811,801	)		2,400,870			85,718,205			–		–		13,943,716		147,803,390
Road & Rail — 0.0%
TuSimple Holdings, Inc.
		107,440,372		34,720,392		(68,336,226	)		(275,689,876	)		201,865,338			–		–		–		–
Software — 8.6%
Materialise NV
		59,636,430		21,877,040		(63,239,996	)		(76,998,323	)		58,724,849			–		–		–		–
PagerDuty, Inc.
		215,727,928		222,662,820		(256,823,608	)		(2,294,738	)		37,183,045			–		–		7,200,780		216,455,447

	Value ($) at 7/31/2022		Purchases Cost ($)		Sales Proceeds ($)			Net Realized Gain/(Loss) ($)			Net Change in Unrealized Appreciation (Depreciation) ($)			Dividend Income ($)		Capital Gain Distributions ($)		Number of Shares at 4/30/2023		Value ($) at 4/30/2023
UiPath, Inc.
		413,196,381		474,446,335		(448,451,723	)		20,606,993			(97,005,173	)		–		–		25,766,535		362,792,813
	$	4,834,169,745	$	4,341,511,912	$	(5,220,358,466	)	$	(1,329,782,986	)	$	400,625,109		$	–	$	–		248,325,023		$3,026,165,314

ARK Innovation ETF	Level 1		Level 2		Level 3		Total
Assets
Common Stocks^‡	$	6,704,493,205	$	–	$	–	$	6,704,493,205
Money Market Fund		1,261,828		–		–		1,261,828
Total	$	6,705,755,033	$	–	$	–	$	6,705,755,033